Your browser doesn't support javascript.
loading
LHX2 facilitates the progression of nasopharyngeal carcinoma via activation of the FGF1/FGFR axis.
Xie, Tao; Du, Kunpeng; Liu, Wei; Liu, Chunshan; Wang, Baiyao; Tian, Yunhong; Li, Rong; Huang, Xiaoting; Lin, Jie; Jian, Haifeng; Zhang, Jian; Yuan, Yawei.
Affiliation
  • Xie T; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Du K; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Liu W; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Liu C; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Wang B; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Tian Y; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Li R; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Huang X; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Lin J; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Jian H; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China.
  • Zhang J; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China. zhangjian@gzhmu.edu.cn.
  • Yuan Y; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou Province, People's Republic of China. yuanyawei@gzhmu.edu.cn.
Br J Cancer ; 127(7): 1239-1253, 2022 10.
Article in En | MEDLINE | ID: mdl-35864158

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / MicroRNAs Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2022 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nasopharyngeal Neoplasms / MicroRNAs Type of study: Prognostic_studies Limits: Humans Language: En Journal: Br J Cancer Year: 2022 Type: Article